EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.1 USD | -2.31% |
|
-2.00% | +12.92% |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 10 M€ | +10.64% | ||
| 0.09% | 560 M€ | +8.84% | - | |
| 0.09% | 0 M€ | 0.00% | - | |
| 0.08% | 1,166 M€ | +0.26% | - | |
| 0.08% | 607 M€ | +0.05% | - | |
| 0.08% | 36 M€ | +9.83% | - | |
| 0.07% | 414 M€ | +9.92% | - | |
| 0.06% | 324 M€ | +6.70% | - | |
| 0.06% | 40 M€ | +6.57% | - | |
| 0.06% | 8 M€ | +5.12% | - | |
| 0.06% | 31 M€ | +0.20% | - | |
| 0.06% | 20 M€ | +5.12% | - | |
| 0.05% | 15 M€ | -1.62% | - | |
| 0.04% | 17 M€ | +3.59% | - | |
| 0.04% | 9 M€ | +9.79% | - | |
| 0.04% | 18 M€ | +3.94% | - | |
| 0.03% | 104 M€ | +4.37% | - | |
| 0.03% | 6 M€ | +3.89% | ||
| 0.02% | 6 M€ | -4.26% | - | |
| 0.02% | 8 M€ | +1.08% | - | |
| 0.02% | 753 M€ | +1.06% | - | |
| 0.02% | 2 M€ | +3.16% | - | |
| 0.02% | 55 M€ | +0.86% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
88.14
USD
Average target price
96.31
USD
Spread / Average Target
+9.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.92% | 53.11B | |
| +9.55% | 222B | |
| +14.41% | 195B | |
| +24.02% | 148B | |
| +33.92% | 113B | |
| +4.18% | 66.45B | |
| +3.16% | 50.03B | |
| -4.32% | 38.8B | |
| -1.99% | 34.85B | |
| +23.04% | 30.98B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation
